Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges
Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...
Too Old to Operate4d
Tardive Dyskinesia Treatment Updates From 2024
Lyu X, Li Z, Chen S, et al. Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia. Clin Neurophysiol. 2024;166:20-30. doi:10 ...
News Tribune4d
Promising schizophrenia drug shows mixed results
Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday.
When Dopamine is too much of a good thing
Maria welcomes Dr. Anna Lembke MD, Professor & Medical Director of Addiction Medicine at Stamford University to discuss ...